{
  "cik": 2022626,
  "cik_padded": "0002022626",
  "entityName": "Upstream Bio, Inc.",
  "fiscal_years": [
    {
      "accn": "0001193125-26-126188",
      "filed": "2026-03-26",
      "fiscal_year": 2025,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 165000.0,
        "cash": 101578000.0,
        "eps_diluted": -2.66,
        "free_cash_flow": -133440000.0,
        "net_income": -143443000.0,
        "operating_cash_flow": -133275000.0,
        "operating_income": -160361000.0,
        "revenue": 2854000.0,
        "stockholders_equity": 339771000.0,
        "total_assets": 353772000.0,
        "total_liabilities": 14001000.0
      },
      "period_end": "2025-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.041207166002984366,
        "revenue_growth_yoy": 0.2042194092827004,
        "roa_avg2y": -0.34337413568787695,
        "roa_period_end": -0.4054673631604536,
        "roe_avg2y": -0.35434517052998743,
        "roe_period_end": -0.4221755241029988
      }
    },
    {
      "accn": "0001193125-26-126188",
      "filed": "2026-03-26",
      "fiscal_year": 2024,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 511000.0,
        "cash": 325892000.0,
        "eps_diluted": -5.58,
        "free_cash_flow": -59683000.0,
        "net_income": -62806000.0,
        "operating_cash_flow": -59172000.0,
        "operating_income": -77764000.0,
        "revenue": 2370000.0,
        "stockholders_equity": 469852000.0,
        "total_assets": 481719000.0,
        "total_liabilities": 11867000.0
      },
      "period_end": "2024-12-31",
      "ratio_units": {
        "leverage": "ratio",
        "revenue_growth_yoy": "ratio",
        "roa_avg2y": "ratio",
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio",
        "roe_period_end": "ratio"
      },
      "ratios": {
        "leverage": 0.025256889403471733,
        "revenue_growth_yoy": -0.004201680672268907,
        "roa_avg2y": -0.2097318994117716,
        "roa_period_end": -0.13037891384811479,
        "roe_avg2y": -0.3622803020252303,
        "roe_period_end": -0.1336718796557214
      }
    },
    {
      "accn": "0001193125-26-126188",
      "filed": "2026-03-26",
      "fiscal_year": 2023,
      "form": "10-K",
      "fundamental_units": {
        "capex": "USD",
        "cash": "USD",
        "eps_diluted": "USD/shares",
        "free_cash_flow": "USD",
        "net_income": "USD",
        "operating_cash_flow": "USD",
        "operating_income": "USD",
        "revenue": "USD",
        "stockholders_equity": "USD",
        "total_assets": "USD",
        "total_liabilities": "USD"
      },
      "fundamentals": {
        "capex": 144000.0,
        "cash": 25833000.0,
        "eps_diluted": -12.95,
        "free_cash_flow": -38070000.0,
        "net_income": -20537000.0,
        "operating_cash_flow": -37926000.0,
        "operating_income": -40114000.0,
        "revenue": 2380000.0,
        "stockholders_equity": -123126000.0,
        "total_assets": 117198000.0,
        "total_liabilities": 9389000.0
      },
      "period_end": "2023-12-31",
      "ratio_units": {
        "roa_period_end": "ratio",
        "roe_avg2y": "ratio"
      },
      "ratios": {
        "roa_period_end": -0.17523336575709483,
        "roe_avg2y": 0.17914262411625909
      }
    },
    {
      "accn": "0000950170-25-037621",
      "filed": "2025-03-12",
      "fiscal_year": 2022,
      "form": "10-K",
      "fundamental_units": {
        "stockholders_equity": "USD"
      },
      "fundamentals": {
        "stockholders_equity": -106155000.0
      },
      "period_end": "2022-12-31",
      "ratios": {}
    }
  ],
  "latest_filing": {
    "accn": "0001193125-26-126188",
    "filed": "2026-03-26",
    "form": "10-K"
  },
  "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.",
  "schema_version": "1",
  "sic": "2834",
  "sic_description": "Pharmaceutical Preparations",
  "source_urls": {
    "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0002022626.json",
    "sec_submissions": "https://data.sec.gov/submissions/CIK0002022626.json"
  },
  "ticker": "UPB"
}